The updated Mantis provides researchers a tool for the automated interpretation of cancer-related somatic variants, including variants of unknown significance.
Signifikance's platform is currently used for analyzing and interpreting cancer variants but will soon support prenatal screening and testing as well.
The company will use the funds to launch a newly developed platform for sharing data and collaborating on genomic research projects.
OGT is one of five companies selected to receive a second grant from the UK's Genomics England project, which it will use to continue developing a variant interpretation solution.
Scientists from Los Alamos National Laboratory have written a computer program to identify bacteria and viruses in metagenomes with fewer false positive matches.
In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.
Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.
Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.
Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.